Antibody Engineering: Advances From the Use of Escherichia coli Expression Systems

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Bio/Technology

• Publication date

  1991-06-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1038/NBT0691-545PMID 1367224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique

  1991cited by this paper
• Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603.

  1991cited by this paper
• Renaturation, Purification and Characterization of Recombinant Fab-Fragments Produced in Escherichia coli

  1991cited by this paper
• Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells.

  1990cited by this paper
• Catalytic antibodies.

  1990cited by this paper
• Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding

  1990cited by this paper
• A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins.

  1990cited by this paper
• Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity.

  1990cited by this paper
• The glycopeptides of the mouse immunoglobulin A T15.

  1990cited by this paper
• A comparison of strategies to stabilize immunoglobulin Fv-fragments.

  1990cited by this paper
• Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli.

  1990cited by this paper
• Secretion of heterologous proteins in Escherichia coli.

  1990cited by this paper
• Expression and secretion of aequorin as a chimeric antibody by means of a mammalian expression vector.

  1990cited by this paper
• Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.

  1990cited by this paper
• Antibodies from Escherichia coli

  1990cited by this paper
• A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv.

  1990cited by this paper
• Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor.

  1990cited by this paper
• Structural features of the McPC603 Fab fragment not defined in the X‐ray structure

  1990cited by this paper
• IgM--molecular requirements for its assembly and function.

  1989cited by this paper
• A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

  1989cited by this paper
• Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

  1989cited by this paper
• Genetically engineered antibody molecules.

  1989cited by this paper
• Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library.

  1989cited by this paper
• Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.

  1989cited by this paper
• Polymemse Chain Reaction Using Mixed Primers: Cloning of Human Monoclonal Antibody Variable Region Genes from Single Hybridoma Cells

  1989cited by this paper
• Generation of a catalytic antibody by site-directed mutagenesis.

  1989cited by this paper
• Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

  1989cited by this paper
• Expression of functional antibody Fv and Fab fragments in Escherichia coli.

  1989cited by this paper
• Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda.

  1989cited by this paper
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

  1988cited by this paper
• Nonprecipitating Asymmetric Antibodies

  1988cited by this paper
• Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.

  1988cited by this paper
• Novel antibodies by DNA manipulation.

  1988cited by this paper
• Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

  1988cited by this paper
• Nonprecipitating asymmetric antibodies.

  1988cited by this paper
• Selective removal of alpha heavy-chain glycosylation sites causes immunoglobulin A degradation and reduced secretion

  1988cited by this paper
• Single-chain antigen-binding proteins.

  1988cited by this paper
• Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

  1988cited by this paper
• Glycosylation of a VH residue of a monoclonal antibody against alpha (1- ---6) dextran increases its affinity for antigen

  1988cited by this paper
• Escherichia coli secretion of an active chimeric antibody fragment.

  1988cited by this paper
• Effect of trimming inhibitors on the secretion and biological activity of a murine IgE monoclonal antibody.

  1987cited by this paper
• Molecular mechanisms of protein secretion: the role of the signal sequence.

  1986cited by this paper
• Proteolytic dissection of a hapten binding site

  1986cited by this paper
• Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.

  1985cited by this paper
• Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.

  1985cited by this paper
• Affinity chromatography : a practical approach

  1985cited by this paper
• Methionine or not methionine at the beginning of a protein

  1985cited by this paper
• Expression of a biologically active fragment of human IgE ε chain in Escherichia coli

  1984cited by this paper
• Properties of a human immunoglobulin epsilon-chain fragment synthesized in Escherichia coli.

  1984cited by this paper
• The influence of messenger RNA secondary structure on expression of an immunoglobulin heavy chain in Escherichia coli.

  1984cited by this paper
• The generation of diversity in phosphorylcholine-binding antibodies.

  1984cited by this paper
• Recombinant antibodies possessing novel effector functions

  1984cited by this paper
• Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli.

  1984cited by this paper
• Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli.

  1984cited by this paper
• Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli.

  1984cited by this paper
• Biological significance of carbohydrate chains on monoclonal antibodies.

  1983cited by this paper
• The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A

  1983cited by this paper
• Biosynthesis and regulation of immunoglobulins.

  1983cited by this paper
• Biosynthesis of murine immunoglobulin D: Heterogeneity of glycosylation

  1982cited by this paper
• Complete amino acid sequence of a mouse immunoglobulin alpha chain (MOPC 511).

  1980cited by this paper
• Plasma cell immunoglobulin M molecules. Their biosynthesis, assembly, and intracellular transport

  1979cited by this paper
• The antibody combining site.

  1977cited by this paper
• Studies of the mechanism of tunicamycin in hibition of IgA and IgE secretion by plasma cells.

  1977cited by this paper
• Evolution of the Immunoglobulins

  1975cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site.

  1974cited by this paper
• Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins.

  1970cited by this paper
• Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains.

  1970cited by this paper

• A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab

  2023cites this paper
• Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging

  2018cites this paper
• Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion

  2017cites this paper
• Cytosolic expression of functional Fab fragments in Escherichia coli using a novel combination of dual SUMO expression cassette and EnBase® cultivation mode

  2017cites this paper
• Immuno-based detection of Shiga toxin-producing pathogenic Escherichia coli in food – A review on current approaches and potential strategies for optimization

  2015cites this paper
• Shiga Toxin-Producing Escherichia coli (STEC) Detection Strategies with Formalin-Fixed STEC Cells

  2015cites this paper
• Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor.

  2013cites this paper
• Effect of culture medium, host strain and oxygen transfer on recombinant Fab antibody fragment yield and leakage to medium in shaken E. coli cultures

  2013cites this paper
• VIRAL ION CHANNEL PRODUCTION FOR STRUCTURAL STUDIES

  2011cites this paper
• Herstellung und Charakterisierung von rekombinanten, ETA-basierten CD64-Immuntoxinen zur Bekämpfung von dysregulierten Makrophagen bei chronischen Hautentzündungen

  2010cites this paper
• Structure-function studies in antibodies and glycosyltransferases

  2007cites this paper
• Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting

  2006cites this paper
• Phage display vectors for the in vitro generation of human antibody fragments.

  2005cites this paper
• A Single-chain Fragment Variable Recombinant Antibody against F5 Fimbria of Enterotoxigenic Escherichia coli Inhibits Agglutination of Horse Red Blood Cells Induced by F5 Protein

  2005cites this paper
• Nevanen Enantioselective antibody fragments

  2004cites this paper
• Mating antibody phage display with proteomics.

  2004cites this paper
• [Monoclonal antibodies and therapeutics].

  2004cites this paper
• Enantioselective antibody fragments

  2004cites this paper
• Anticorps monoclonaux et thérapeutique

  2004cites this paper
• Innovative tools for detection of plant pathogenic viruses and bacteria

  2003cites this paper
• Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm.

  2003cites this paper
• The Rapeutic Antibodies and Antibody Fusion Proteins

  2003cites this paper
• Therapeutic anticancer antibodies

  2003cites this paper
• Functional characterization of an anti‐estradiol antibody by site‐directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the VL domain in estradiol recognition

  2002cites this paper
• ents Produced in Escherichia coli : Engineering , Folding and Antigen Binding

  2001cites this paper
• Improved Production by Domain Inversion of Single-Chain Fv Antibody Fragment Against High Molecular Weight Proteoglycan for the Radioimmunotargeting of Melanoma

  2001influential citation
• Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor.

  2001cites this paper
• An engineering study of the design, integration and control of antibody fragment production processes

  2001cites this paper
• Expression and Detection of ScFvB9 and its Mutant in Recombinant Phage Antibody System

  2001cites this paper
• Recombinant Antibodies

  2001cites this paper
• Rapid two-step purification of a recombinant mouse Fab fragment expressed in Escherichia coli.

  2001cites this paper
• Expression of mouse anticreatine kinase (MAK33) monoclonal antibody in the yeast Hansenula polymorpha

  2001cites this paper
• Affinity-reversed-phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth.

  2001cites this paper
• Structural stability and binding properties of soluble and membrane-anchored recombinant antibodies

  2001cites this paper
• Principles of Genetic Engineering for Escherichia coli

  2001cites this paper
• Secretion of Homologous and Heterologous Recombinant Proteins in Escherichia Coli and Other Gram-Negative Bacteria by Using a New Secretion System

  2001cites this paper
• Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct.

  2000cites this paper
• Three-step purification of bacterially expressed human single-chain Fv antibodies for clinical applications.

  2000cites this paper
• Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.

  2000cites this paper
• The use of phage display for the development of tumour targeting agents.

  2000cites this paper
• Production of Humanized Fab Fragment against Human High Affinity IgE Receptor in Pichia pastoris

  2000cites this paper
• Production and in vitro refolding of a single-chain antibody specific for human plasma apolipoprotein A-I.

  2000cites this paper
• Fully "Recombinant Enzyme-Linked Immunosorbent Assays" Using Genetically Engineered Single-Chain Antibody Fusion Proteins for Detection of Citrus tristeza virus.

  2000cites this paper
• A bacterial single-chain Fv antibody fragment that inhibits binding of its parental anti-E-selectin monoclonal antibody to activated human endothelial cells.

  1999cites this paper
• Molecular engineering of the catalytic antibody 20G9.

  1999cites this paper
• Crystal Structure of Anti-Hen Egg White Lysozyme Antibody (HyHEL-10) Fv-Antigen Complex

  1999cites this paper
• Immunoassay for wheat processing quality: utilization of a sandwich assay incorporating an immobilized single-chain fragment.

  1999cites this paper
• High-level expression of a recombinant protein in Klebsiella planticola owing to induced secretion into the culture medium

  1999cites this paper
• Analysis of the V genes coding for a monospecific human antibody to myosin and functional expression of single chain Fv fragments

  1999cites this paper
• Development of recombinant antibody technology for application in plant pathogen diagnosis

  1999cites this paper
• Strategies for producing therapeutic antibodies in yeast.

  1999cites this paper
• Intracellular Immunization of Prokaryotic Cells against a Bacteriotoxin

  1998cites this paper
• Creating and engineering human antibodies for immunotherapy.

  1998cites this paper
• Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.

  1998cites this paper
• Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.

  1998cites this paper
• Surface plasmon resonance biosensors as a tool in antibody engineering.

  1998cites this paper
• Constructions and expressions of anti-ABA scFv genes in bacteria, yeast and plants

  1997cites this paper
• The kil gene of the ColE1 plasmid of Escherichia coli controlled by a growth-phase-dependent promoter mediates the secretion of a heterologous periplasmic protein during the stationary phase

  1997cites this paper
• Development of genetically engineered mouse/human chimeric and single chain antibodies against human brain glioma: A preliminary report

  1997cites this paper
• The kil gene of the ColE1 plasmid of Escherichia coli controlled by a growth-phase-dependent promoter mediates the secretion of a heterologous periplasmic protein during the stationary phase.

  1997cites this paper
• Controlled secretion into the culture medium of a hybrid -glucanase by Acetobacter methanolicus mediated by the kil gene of Escherichia coli located on a Tn5 -derived transposon

  1997cites this paper
• Engineering subunit association of multisubunit proteins: a dimeric streptavidin.

  1997cites this paper
• T-cell receptor structure and TCR complexes.

  1997cites this paper
• Extracellular production of a hybrid β-glucanase from Bacillus by Escherichia coli under different cultivation conditions in shaking cultures and bioreactors

  1997cites this paper
• Biocatalysts in detoxication of drugs of abuse.

  1997cites this paper
• Expression and functional characterization of a single chain Fv antibody directed against secretions involved in plant nematode infection process.

  1996cites this paper
• Production of Antibody Fragments in Escherichia coli

  1996cites this paper
• Preparation, purification and crystallization of antibody Fabs and single-chain Fv domains

  1996cites this paper
• Production of recombinant antibody fragments in microorgansms.

  1996cites this paper
• The Use of Immobilized Antibody Fragments to Detect and Remove Organic Pollutants in the Environment

  1996cites this paper
• In vitro folding of inclusion body proteins

  1996cites this paper
• A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines.

  1996cites this paper
• Antibody engineering studies using filamentous bacteriophage display technology.

  1996cites this paper
• Antibody catalysis of pericyclic reactions.

  1996cites this paper
• Polyclonal Preparations of Anti-Tetanus Toxoid Antibodies Derived from a Combinatorial Library Confer Protection

  1995cites this paper
• Expression of properly folded catalytic antibodies in Escherichia coli.

  1995cites this paper
• Expression studies of catalytic antibodies.

  1995cites this paper
• Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells

  1995cites this paper
• Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro

  1995cites this paper
• Selection of Escherichia coli Expression Systems

  1995cites this paper
• Paratope characterization by structural modelling of two anti-cortisol single-chain variable fragments produced in E. coli.

  1995cites this paper
• Characterization of an anti-CD44 single-chain FV antibody that stimulates natural killer cell activity and induces TNF alpha release.

  1995cites this paper
• Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.

  1995cites this paper
• Immunotherapy of plant viral diseases.

  1995cites this paper
• Cloning, expression, and purification of an anti-desipramine single chain antibody in NS/O myeloma cells.

  1995cites this paper
• Separation and concentration of bacteria with immobilized antibody fragments.

  1995cites this paper
• The biotechnology and applications of antibody engineering

  1995cites this paper
• Generation of Rabbit Monoclonal Antibody Fragments from a Combinatorial Phage Display Library and Their Production in the Yeast Pichia pastoris

  1995cites this paper
• High-Level Production and Long-Term Storage of Engineered Antibodies in Transgenic Tobacco Seeds

  1995cites this paper
• Two-Phase Approach for the Expression of High-Affinity Human Anti-Human Immunodeficiency Virus Immunoglobulin Fab Domains in Escherichia coli

  1995cites this paper
• A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli.

  1995cites this paper
• Bacteriocin release proteins: mode of action, structure, and biotechnological application.

  1995cites this paper
• Purification and application of a single-chain Fv antibody fragment specific to hepatitis B virus surface antigen.

  1995cites this paper
• Expression of Monovalent and Bivalent Antibody Fragments in Escherichia coli

  1995cites this paper
• Characterization of four nucleic acid-binding single-chain Fv fragments by direct and competitive solid-phase radioimmunoassays.

  1994cites this paper
• Control options of plant pathogens in native plant communities in south-western Australia

  1994cites this paper
• Heterologous protein secretion and the versatile Escherichia coli haemolysin translocator.

  1994cites this paper
• Expression of a recombinant sheep IgE gene.

  1994cites this paper
• Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles.

  1994cites this paper
• Application of an alkaline phosphatase fusion protein system suitable for efficient screening and production of Fab-enzyme conjugates in Escherichia coli.

  1994cites this paper